Furthermore, among patients with a 1-PSA < 4.0 ng/mL, those with an increase of 18% or more from 1-PSA to 2-PSA had a significantly higher risk of developing prostate cancer than those with no changes between 1-PSA and 2-PSA. This evidence concerns the gene KLK3 and prostate cancer.